Private Sector Constituency to Stop TB Partnership

Patients in some remote TB-endemic communities struggle to access fast, reliable screenings for the disease. To improve access, healthcare practitioners are leveraging #AI and #CAD tools to expedite and expand patient intake and result processing. Read more about how AI is alleviating #tuberculosis care gaps: https://lnkd.in/dTjtcrwy #ruraldevelopment #tbdetection #healthtech

Chest x-rays play a critical role in #TB early detection, especially in vulnerable populations like children and higher risk or #immunocompromised adults. Broader chest X-ray deployment, however, is constrained by the shortage of human readers and radiologists. To overcome these challenges, many practitioners and health systems have successfully deployed AI-powered CAD software, which automates the interpretation of digital chest x-ray images, streamlining care for patients and saving time for practitioners. Find out how these tools accelerate the detection and care of #TB: https://lnkd.in/dTjtcrwy #innovativecare #tbdiagnosis #techforgood #CXR

Although AI’s potential to support healthcare systems is a common discussion point among global health leaders, these tools are still in their infancy and have yet to be fully adopted in the fight against #tb. Structural barriers, like insufficient technological infrastructure in some endemic communities, are limiting more widespread #AI adoption. Discover how stakeholders can identify and overcome infrastructure barriers and more fully activate the power of AI to #endTB: https://lnkd.in/dTjtcrwy #privatesectorengagement #tuberculosis #tbawareness

Despite the potential for leveraging AI technologies to better combat #tuberculosis, their adoption has been slow in many TB-endemic communities. To advance utilization of #AI tools, global health stakeholders must better articulate AI’s value proposition, including how it can be used to improve screening capabilities, strengthen patient data analysis, and reduce inequities across the care continuum. Read more about harnessing the power of AI to tackle TB: https://lnkd.in/dTjtcrwy #emergingtech #tbdiagnosis #ai4good

Stay tuned for the next edition of our TB in Tidbits, going live TOMORROW! 🔴 The incredible potential of M72, a promising tuberculosis vaccine candidate with the potential to fundamentally transform future efforts to curtail and eradicate the disease 🔴 The influence #TB patients had on the evolution of these essential furnishings 🔴 The potential of an existing TB vaccine in protecting type 1 #diabetics from COVID-19 and other diseases 🔴 The renewed interest in the many linkages between TB and #AMR amongst global health stakeholders #TBinTidbits

Until #tuberculosis is eradicated, the search for new, more effective #TB drugs must continue. The #TBAlliance, a not-for-profit product development partnership, has successfully advanced multiple drug candidates as part of combination regimens, including child-friendly formulations of first-line medicines. To date, the Alliance has distributed over 1.2 million treatment courses to the 90+ countries that bear over 75% of the global childhood TB burden. Read more about how collaborations like the TB Alliance can help ensure continued #access to high-quality treatments in high-burden communities: https://lnkd.in/gXBfNSX4 #healthcaresystems #drugresearch #globalhealth

The Rome 5 Initiative, a cross-sectoral collaboration, aims to advance HIV and TB services for children. The program focuses on resolving operational bottlenecks to bolster healthcare services for children impacted by both diseases. Find out more about how private sector engagements like the Rome 5 Initiative could be leveraged in the ongoing fight against TB: https://lnkd.in/gXBfNSX4 #childrenshealth #operationalbottlenecks #childhoodTB

In many cases, existing #TB treatments and therapies are too slow at combatting the disease. By leveraging personal health #data and advanced scanning techniques, the Predict-TB Consortium, comprised of partners in Africa, America, Asia, and Europe, is working to shorten treatment times for TB patients. Find out more: https://lnkd.in/gXBfNSX4 #TBtreatment #TBpatient #healthdata #tbdiagnostics

Many TB treatment programs do not sufficiently tailor their regimens to the needs of individual #patients. The Predict-TB Consortium — implemented by program partners in Africa, America, Asia, and Europe — seeks to provide more personalized treatment regimens for eligible patients through individualized therapy. Learn more about the benefits of personalized TB care: https://lnkd.in/gXBfNSX4 #TBtreatment #healthsystems #personalizedcare

Common TB treatment regimens have many drawbacks: they can take too long to implement, can be too complicated to administer, and can be ineffective at fighting drug-resistant strains of the disease (MDR-TB). PAN-TB, part of the EU's IMI AMR Accelerator, is a collaborative effort to develop novel drug regimens that are more effective against drug-resistant strains, have shorter treatment durations, and are more straightforward to administer. Learn more about how these innovative drug regimens have the potential to help in the fight against TB: https://lnkd.in/gXBfNSX4 #noveldrugregimens #standardofcare #globalhealth